PubMed

Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.

Zhou Z, Althin R, Sforzolini BS, Dhawan R.

Br J Ophthalmol. 2004 Nov;88(11):1391-4.PMID: 15489479 [PubMed - indexed for MEDLINE]Related articlesFree article

Persistency with latanoprost or timolol in primary open-angle glaucoma suspects.

Schwartz GF, Reardon G, Mozaffari E.

Am J Ophthalmol. 2004 Jan;137(1 Suppl):S13-6.PMID: 14697910 [PubMed - indexed for MEDLINE]Related articles

Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients.

Arend O, Harris A, Wolter P, Remky A.

Acta Ophthalmol Scand. 2003 Oct;81(5):474-9.PMID: 14510794 [PubMed - indexed for MEDLINE]Related articles

Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.

Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.

J Glaucoma. 2008 Apr-May;17(3):233-7.PMID: 18414111 [PubMed - indexed for MEDLINE]Related articles

Latanoprost versus combined timolol and dorzolamide.

Bron AM, Emmerich KH.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S148-54. Review.PMID: 12204712 [PubMed - indexed for MEDLINE]Related articles

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.

Pajic B; Conductors of the Swiss COSOPT Survey (CSCS).

Curr Med Res Opin. 2003;19(2):95-101.PMID: 12740152 [PubMed - indexed for MEDLINE]Related articles

Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.

Hamacher T, Schinzel M, Schölzel-Klatt A, Neff HM, Maier H, Schlaffer G, Beausencourt E, Jütte M, Scholz R, Lorger C, Stewart WC.

Br J Ophthalmol. 2004 Oct;88(10):1295-8.PMID: 15377554 [PubMed - indexed for MEDLINE]Related articlesFree article

Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort study.

Diestelhorst M, Schaefer CP, Beusterien KM, Plante KM, Fain JM, Mozaffari E, Dhawan R.

Eur J Ophthalmol. 2003 Jul;13 Suppl 4:S21-9.PMID: 12948050 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.

Pillunat LE, Larsson LI; European and Canadian Latanoprost Study Group.

Br J Ophthalmol. 2003 Dec;87(12):1492-6.PMID: 14660460 [PubMed - indexed for MEDLINE]Related articlesFree article

Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.

Tamer C, Oksüz H.

Ophthalmic Res. 2007;39(1):24-31. Epub 2006 Dec 11.PMID: 17164574 [PubMed - indexed for MEDLINE]Related articles

The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.

Costagliola C, Parmeggiani F, Antinozzi PP, Caccavale A, Cotticelli L, Sebastiani A.

Exp Eye Res. 2005 Nov;81(5):610-5. Epub 2005 Jun 8.PMID: 15949795 [PubMed - indexed for MEDLINE]Related articles

Patient persistency with pharmacotherapy in the management of glaucoma.

Reardon G, Schwartz GF, Mozaffari E.

Eur J Ophthalmol. 2003 Jul;13 Suppl 4:S44-52.PMID: 12948052 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

Ann Pharmacother. 2008 Apr;42(4):498-504. Epub 2008 Mar 25.PMID: 18364402 [PubMed - indexed for MEDLINE]Related articles

A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.

Day DG, Schacknow PN, Sharpe ED, Ellyn JC, Kulze JC 3rd, Threlkeld AB, Jones ED, Brown RH, Jenkins JN, Stewart WC.

J Ocul Pharmacol Ther. 2004 Oct;20(5):383-92.PMID: 15650513 [PubMed - indexed for MEDLINE]Related articles

Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association.

Italian Multicentric Open Randomized Study under the aegis of A.I.S.G.: Final Results and Official Report.

Acta Ophthalmol Scand Suppl. 2000;(232):49-50. No abstract available. PMID: 11235535 [PubMed - indexed for MEDLINE]Related articles

Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database.

Lafuma A, Berdeaux G.

Curr Med Res Opin. 2008 May;24(5):1519-27. Epub 2008 Apr 14.PMID: 18413015 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments.

Haverkamp F, Wuensch S, Fuchs M, Stewart WC.

Eur J Ophthalmol. 2004 Sep-Oct;14(5):407-15.PMID: 15506603 [PubMed - indexed for MEDLINE]Related articles

Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.

Reardon G, Schwartz GF, Mozaffari E.

Clin Ther. 2003 Apr;25(4):1172-85.PMID: 12809964 [PubMed - indexed for MEDLINE]Related articles

A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.

Martínez A, Sánchez M.

Curr Med Res Opin. 2006 Jan;22(1):67-73.PMID: 16393432 [PubMed - indexed for MEDLINE]Related articles